GT
Gaurav Tripathi
Kashi Clinical Laboratories, Temple University Hospital, University of Calgary
Research areas: Medicine · Hepatology · Liver Disease and Transplantation · Alcohol Consumption and Health Effects · Gut microbiota and health
0000-0002-1820-6547
Employment
-
Kashi Clinical Laboratories HLA-DIT/ Lab Manager/Data Analytical Supervisor/ Director's Assistant2025 - Present
-
Temple University Hospital HLA Director-in Training2023 - 2025
-
University of Calgary Research Scientist/ Post Doc Associate2012 - 2022
-
SGRH Scientist2011 - 2012
-
HUMV Visiting Research Scientist2010 - 2011
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (34)
- Editorial for Special Issue “Technological Advances Around Next-Generation Sequencing” Save
- Novel diagnostics techniques for detection of Coronavirus disease 2019 Save
- Interleukin 17F Gene Polymorphisms and Chronic Kidney Allograft Failure Save
- Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies Save
- Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease Save
- Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease Save
- Lack of both donor and recipient anti-EBV T cells in EBV seronegative recipients of grafts from seropositive donors Save
- Curability and transferability of atopy with allogeneic hematopoietic cell transplantation Save
- Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation Save
- Prediction of susceptible biomarkers for end stage renal disease among North Indians Save
- Interleukin‑1 gene cluster variants in hemodialysis patients with end stage renal disease: An association and meta‑analysis Save
- Cytokine Gene Considerations in Giant Cell Arteritis: IL10 Promoter Polymorphisms and a Review of the Literature Save
- Lack of association between Toll-like receptor 4 gene polymorphisms and giant cell arteritis Save
- Strong relationships between inflammation, atherosclerosis and end stage renal disease Save
- Strong relationships between inflammation, atherosclerosis and end stage renal disease Save
- Association of angiotensin-converting enzyme gene I/D polymorphism with steroid responsiveness in childhood nephrotic syndrome Save
- Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease Save
- Vitamin D receptor genetic variants among patients with end-stage renal disease Save
- Association of proinflammatory cytokines with end stage renal disease Save
- Genetic association of phase I and phase II detoxification genes with recurrent miscarriages among North Indian women Save